TLG Capital

TLG Capital is a London-based private investment firm specializing in frontier markets, with a primary focus on Sub-Saharan Africa. Founded in 2009, the firm utilizes private credit and structured finance to support small and medium-sized enterprises (SMEs) in sectors critical to sustainable development, most notably healthcare. Through its healthcare portfolio and its operating arm, TLG Pharma, the company facilitates the manufacture and distribution of essential medicines, including antiretrovirals and antimalarials, and provides specialized services like oncology care. TLG Capital is recognized for its impact-driven approach, bridging the capital gap in underserved regions while delivering commercial returns.